161 related articles for article (PubMed ID: 12226080)
1. Differential modulation of androgen receptor-mediated transactivation by Smad3 and tumor suppressor Smad4.
Kang HY; Huang KE; Chang SY; Ma WL; Lin WJ; Chang C
J Biol Chem; 2002 Nov; 277(46):43749-56. PubMed ID: 12226080
[TBL] [Abstract][Full Text] [Related]
2. The androgen receptor represses transforming growth factor-beta signaling through interaction with Smad3.
Chipuk JE; Cornelius SC; Pultz NJ; Jorgensen JS; Bonham MJ; Kim SJ; Danielpour D
J Biol Chem; 2002 Jan; 277(2):1240-8. PubMed ID: 11707452
[TBL] [Abstract][Full Text] [Related]
3. Modulation of androgen receptor transactivation by FoxH1. A newly identified androgen receptor corepressor.
Chen G; Nomura M; Morinaga H; Matsubara E; Okabe T; Goto K; Yanase T; Zheng H; Lu J; Nawata H
J Biol Chem; 2005 Oct; 280(43):36355-63. PubMed ID: 16120611
[TBL] [Abstract][Full Text] [Related]
4. From transforming growth factor-beta signaling to androgen action: identification of Smad3 as an androgen receptor coregulator in prostate cancer cells.
Kang HY; Lin HK; Hu YC; Yeh S; Huang KE; Chang C
Proc Natl Acad Sci U S A; 2001 Mar; 98(6):3018-23. PubMed ID: 11248024
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-beta inhibits adipocyte differentiation by Smad3 interacting with CCAAT/enhancer-binding protein (C/EBP) and repressing C/EBP transactivation function.
Choy L; Derynck R
J Biol Chem; 2003 Mar; 278(11):9609-19. PubMed ID: 12524424
[TBL] [Abstract][Full Text] [Related]
6. Synergistic cooperation between Sp1 and Smad3/Smad4 mediates transforming growth factor beta1 stimulation of alpha 2(I)-collagen (COL1A2) transcription.
Zhang W; Ou J; Inagaki Y; Greenwel P; Ramirez F
J Biol Chem; 2000 Dec; 275(50):39237-45. PubMed ID: 11007770
[TBL] [Abstract][Full Text] [Related]
7. Activation of the androgen receptor N-terminal domain by interleukin-6 via MAPK and STAT3 signal transduction pathways.
Ueda T; Bruchovsky N; Sadar MD
J Biol Chem; 2002 Mar; 277(9):7076-85. PubMed ID: 11751884
[TBL] [Abstract][Full Text] [Related]
8. [Effect of dihydrotestosterone on the transcriptions and expressions of Smad3 and Smad4 in LNCaP cell line].
Gu RG; Zhou CW; Ma QZ
Zhonghua Nan Ke Xue; 2006 Mar; 12(3):211-4. PubMed ID: 16597033
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of a transcriptional cross talk between transforming growth factor-beta-regulated Smad3 and Smad4 proteins and orphan nuclear receptor hepatocyte nuclear factor-4.
Chou WC; Prokova V; Shiraishi K; Valcourt U; Moustakas A; Hadzopoulou-Cladaras M; Zannis VI; Kardassis D
Mol Biol Cell; 2003 Mar; 14(3):1279-94. PubMed ID: 12631740
[TBL] [Abstract][Full Text] [Related]
10. TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells.
Zhu ML; Partin JV; Bruckheimer EM; Strup SE; Kyprianou N
Prostate; 2008 Feb; 68(3):287-95. PubMed ID: 18163430
[TBL] [Abstract][Full Text] [Related]
11. Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15(Ink4B) transcription in response to TGF-beta.
Feng XH; Lin X; Derynck R
EMBO J; 2000 Oct; 19(19):5178-93. PubMed ID: 11013220
[TBL] [Abstract][Full Text] [Related]
12. Hoxa-9 represses transforming growth factor-beta-induced osteopontin gene transcription.
Shi X; Bai S; Li L; Cao X
J Biol Chem; 2001 Jan; 276(1):850-5. PubMed ID: 11042172
[TBL] [Abstract][Full Text] [Related]
13. Negative modulation of androgen receptor transcriptional activity by Daxx.
Lin DY; Fang HI; Ma AH; Huang YS; Pu YS; Jenster G; Kung HJ; Shih HM
Mol Cell Biol; 2004 Dec; 24(24):10529-41. PubMed ID: 15572661
[TBL] [Abstract][Full Text] [Related]
14. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells.
Poncelet AC; de Caestecker MP; Schnaper HW
Kidney Int; 1999 Oct; 56(4):1354-65. PubMed ID: 10504488
[TBL] [Abstract][Full Text] [Related]
15. SMAD3 represses androgen receptor-mediated transcription.
Hayes SA; Zarnegar M; Sharma M; Yang F; Peehl DM; ten Dijke P; Sun Z
Cancer Res; 2001 Mar; 61(5):2112-8. PubMed ID: 11280774
[TBL] [Abstract][Full Text] [Related]
16. Androgen receptor interacts with a novel MYST protein, HBO1.
Sharma M; Zarnegar M; Li X; Lim B; Sun Z
J Biol Chem; 2000 Nov; 275(45):35200-8. PubMed ID: 10930412
[TBL] [Abstract][Full Text] [Related]
17. Tip110, the human immunodeficiency virus type 1 (HIV-1) Tat-interacting protein of 110 kDa as a negative regulator of androgen receptor (AR) transcriptional activation.
Liu Y; Kim BO; Kao C; Jung C; Dalton JT; He JJ
J Biol Chem; 2004 May; 279(21):21766-73. PubMed ID: 15031286
[TBL] [Abstract][Full Text] [Related]
18. Human checkpoint protein hRad9 functions as a negative coregulator to repress androgen receptor transactivation in prostate cancer cells.
Wang L; Hsu CL; Ni J; Wang PH; Yeh S; Keng P; Chang C
Mol Cell Biol; 2004 Mar; 24(5):2202-13. PubMed ID: 14966297
[TBL] [Abstract][Full Text] [Related]
19. SMAD3/4-dependent transcriptional activation of the human type VII collagen gene (COL7A1) promoter by transforming growth factor beta.
Vindevoghel L; Lechleider RJ; Kon A; de Caestecker MP; Uitto J; Roberts AB; Mauviel A
Proc Natl Acad Sci U S A; 1998 Dec; 95(25):14769-74. PubMed ID: 9843964
[TBL] [Abstract][Full Text] [Related]
20. c-Jun enhancement of androgen receptor transactivation is associated with prostate cancer cell proliferation.
Chen SY; Cai C; Fisher CJ; Zheng Z; Omwancha J; Hsieh CL; Shemshedini L
Oncogene; 2006 Nov; 25(54):7212-23. PubMed ID: 16732317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
